Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-29 22:49:02 - browse：299

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Will generative AI in health care meet the fate of IBM's Dr. Watson?

WSS

David Sabatini, ex

Focused ultrasound for uterine fibroids: an uphill battle

Steward Health Care has deal to sell doctor network to UnitedHealth

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Why the world’s most expensive drug might be worth the price

Insmed lung disease drug hits target in key Phase 3 trial

hotspot

Wikipedia

entertainment

New air purifier tech could be key to improving indoor air quality

Will generative AI in health care meet the fate of IBM's Dr. Watson?

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Merck, Vertex, and Viking updates

Trump demands the U.S. pay no more for drugs than other countries … again

Latest bird flu infection made farmworker sicker than earlier cases

BioMarin wins approval for gene therapy to treat hemophilia A

The Readout: Lenmeldy, GLP

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

entertainment

Dark money group runs ads on China biotech bill

Supreme Court mifepristone arguments center on docs' right to sue

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Focused ultrasound for uterine fibroids: an uphill battle

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Eliminate the waiting period for sterilization covered by Medicaid

focus

knowledge

knowledge

focus